Research ArticleArticle
Elucidation of the Metabolic Pathways and the Resulting Multiple Metabolites of Almorexant, a Dual Orexin Receptor Antagonist, in Humans
Jasper Dingemanse, Petra Hoever, Matthias Hoch, Alexander Treiber, Winfried Wagner-Redeker, Tommaso Miraval, Gerard Hopfgartner and Kasra Shakeri-Nejad
Drug Metabolism and Disposition February 21, 2013, dmd.112.050120; DOI: https://doi.org/10.1124/dmd.112.050120
Jasper Dingemanse
1 Actelion Pharmaceuticals Ltd;
Petra Hoever
1 Actelion Pharmaceuticals Ltd;
Matthias Hoch
1 Actelion Pharmaceuticals Ltd;
Alexander Treiber
1 Actelion Pharmaceuticals Ltd;
Winfried Wagner-Redeker
2 Swiss BioAnalytics AG;
Tommaso Miraval
3 Swiss BioAnalytics AG
Gerard Hopfgartner
3 Swiss BioAnalytics AG
Kasra Shakeri-Nejad
1 Actelion Pharmaceuticals Ltd;
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
Elucidation of the Metabolic Pathways and the Resulting Multiple Metabolites of Almorexant, a Dual Orexin Receptor Antagonist, in Humans
Jasper Dingemanse, Petra Hoever, Matthias Hoch, Alexander Treiber, Winfried Wagner-Redeker, Tommaso Miraval, Gerard Hopfgartner and Kasra Shakeri-Nejad
Drug Metabolism and Disposition February 21, 2013, dmd.112.050120; DOI: https://doi.org/10.1124/dmd.112.050120
Research ArticleArticle
Elucidation of the Metabolic Pathways and the Resulting Multiple Metabolites of Almorexant, a Dual Orexin Receptor Antagonist, in Humans
Jasper Dingemanse, Petra Hoever, Matthias Hoch, Alexander Treiber, Winfried Wagner-Redeker, Tommaso Miraval, Gerard Hopfgartner and Kasra Shakeri-Nejad
Drug Metabolism and Disposition February 21, 2013, dmd.112.050120; DOI: https://doi.org/10.1124/dmd.112.050120
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement